In brief

Unlike adults, children have a stronger neutrophil response, which might explain why they respond differently to SARS-CoV-2 infection.

© Shutterstock

Comparing COVID-19 in children and adults

22 Jun 2021

Understanding why COVID-19 tends to strike the old but spare the young could inform how to prioritize limited COVID-19 vaccines.

When COVID-19 swept the globe at the beginning of 2020, it soon became clear that the disease hit some much harder than others. Early on in the pandemic, it became apparent that age was a major factor influencing the severity of disease, with the oldest adults most at risk of serious complications and death. At the other extreme, children seem to be largely unaffected by SARS-CoV-2 infection, with most experiencing only mild symptoms or none at all.

Figuring out the mystery of why COVID-19 strikes the old but spares the young could help us identify at-risk individuals, inform the prioritization of vaccination programs and even give us a sense of how long a protective response might last, explained Elizabeth Tham, a Principal Investigator at A*STAR’s Singapore Institute for Clinical Sciences (SICS). Tham is also a Consultant Pediatrician and Head of the Allergy, Immunology and Rheumatology division at the Department of Pediatrics, National University Hospital (NUH).

“This understanding could lay the groundwork for future therapeutics such as convalescent plasma infusions, monoclonal antibodies and vaccine development. It will also impact clinical decision making and healthcare policy including decisions on screening, quarantine and the closure of schools and workplaces,” Tham said.

In a review of the proposed mechanisms behind the age-related differences in responses to SARS-CoV-2, Tham and her colleagues from A*STAR and NUH found that the relatively immature immune systems of children offered them some protection against the disease.

Children’s regulatory T cells exert stronger effects than those found in adults, she said, and their limited pro-inflammatory responses also mean that they are less likely to overproduce cytokines, a feature that is associated with severe lung damage in adults. “The innate immune response in children is also different from adults, with increased activation of neutrophils and decreased circulating monocytes, dendritic cells and natural killer cells,” Tham added.

However, when children develop symptoms of COVID-19, they can be life-threatening. One such condition is a multisystem inflammatory syndrome in children (MIS-C), a post-inflammatory or autoimmune process where the initial infection triggers a systemic immune response. Although the mechanism behind MIS-C is still unclear, the emerging data suggest a possible genetic predisposition as it appears to strike children from certain ethnic groups more frequently than others.

While our understanding of COVID-19 and how it impacts children have come a long way since the pandemic was first recognized, more studies are required for a fuller understanding of the immune response in different age groups, Tham said. To that end, Tham is collaborating with researchers at NUH, the National University of Singapore, and Duke-NUS Medical School to evaluate the role of cross-reactive neutralizing antibodies from seasonal coronaviruses in modulating responses to SARS-CoV-2 in both children and adults, and also to study the longevity of antibody responses in previously COVID-19-infected children.

The A*STAR researchers contributing to the study are from the Singapore Institute for Clinical Sciences (SICS).

Want to stay up to date with breakthroughs from A*STAR? Follow us on Twitter and LinkedIn!


Wong, L.S.Y., Loo, E.X.L., Kang, A.Y.H., Lau, X.H., Tambyah, P.A , et al. Age related differences in immunological responses to SARS-CoV-2. The Journal of Allergy and Clinical Immunology: In Practice 8 (10) 3251-3258 (2020) | article

About the Researcher

Elizabeth Tham received her MBBS from the Yong Loo Lin School of Medicine (YLLSoM), National University of Singapore (NUS) in 2007, where she won the Jane Prize in Pediatrics. Thereafter, she received her specialist training in pediatrics and neonatology at the National University Hospital, Singapore and KK Women’s and Children’s Hospital. She is also a Clinician-Scientist and Assistant Professor at YLLSoM, NUS. She is currently principal investigator at A*STAR’s Singapore Institute for Clinical Sciences (SICS), where she leads the Child Health domain in the Growing Up in Singapore Towards Healthy Outcomes (GUSTO) and Singapore PREconception study of long-term maternal and child Outcome (S-PRESTO) cohort studies. Her research interests include studying the risk factors and signs of childhood allergic disorders, and the role of skin, gut and environmental microbiome in modulating risk and disease control.

This article was made for A*STAR Research by Wildtype Media Group